Price history
¥2,314Latest+24.6%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview
Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
News
Key numbersShowing 8 of 20
PER
53.3How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.PBR
9.99How many times the company's net assets? Around 1x is generally considered a benchmark.ROE
18.7%Earning power. A figure above 10% is generally considered good.Dividend yield
0.0%The annual dividend as a percentage of the share price.Market capitalization
¥35bnShare price × number of shares. The value of the entire company.Equity ratio
81.4%The proportion of assets funded by money that does not have to be repaid.Operating margin
47.5%The percentage of revenue remaining from the company’s core business.Revenue growth (3 years)
27.1%The average annual growth in sales over the past three years.What to watch next
Full-scale rollout of the new AI feature suite, including AI visit scheduling and routing, AI home-visit nursing care plans, and reporting, and its impact on the number of contracted stations and upselling, including pricing and scope of use
Second half of 2026 to 2027Impact HighLikelihood Medium
Expansion of adoption and accumulation of recurring revenue as the regional comprehensive care platform けあログっと expands its functionality, including discharge support and coordination with regional healthcare providers
Second half of 2026 to 2027Impact MediumLikelihood Medium
Avoidance of delays in system responses to regulatory changes, such as revisions to medical and long-term care reimbursement, and containment of their impact on customer retention and churn
Dependent on the timing of regulatory revisions; monitor closelyImpact HighLikelihood Medium
Whether operational changes and higher costs arising from dependence on external generative AI providers, including developments in generative AI regulation, become apparent
From 2026 onward; ongoingImpact MediumLikelihood Low
Confirmation of improvement in the “next KPIs” after iBow surpassed 100 million cumulative visits, including the visit growth rate, active-user ratio, and churn rate
Next earnings disclosure cycleImpact MediumLikelihood High
What to watch next
Who owns itTop holders total 80.1%
Listed holders 80.1%Everyone else 19.9%
Nakano Taketo (中野 剛人)39.02%
Kitamura Asako (北村 亜沙子)16.24%
株式会社日本カストディ銀行 (Trust Account)5.77%
GOLDMAN SACHS INTERNATIONAL4.66%
SUMITOMO CORPORATION (SUMITOMO SHOJI KAISHA,LTD.)4.50%
The Master Trust Bank of Japan, Ltd. (Trust Account)3.34%
GOVERNMENT OF NORWAY1.91%
島田 亨1.89%
2 other listed holders2.73%
| Holder | Ownership (%) |
|---|---|
| Nakano Taketo (中野 剛人) | 39.02 |
| Kitamura Asako (北村 亜沙子) | 16.24 |
| 株式会社日本カストディ銀行 (Trust Account) | 5.77 |
| GOLDMAN SACHS INTERNATIONAL | 4.66 |
| SUMITOMO CORPORATION (SUMITOMO SHOJI KAISHA,LTD.) | 4.50 |
| The Master Trust Bank of Japan, Ltd. (Trust Account) | 3.34 |
| GOVERNMENT OF NORWAY | 1.91 |
| 島田 亨 | 1.89 |
| 2 other listed holders | 2.73 |
This company's documents
Timely disclosures
- 2026-10-08Notice of the Third-Quarter Financial Results Briefing for the Fiscal Year Ending December 2026 for Institutional and Individual Investors
- 2026-08-20Notice of the Release of the Transcript and Video of the Financial Results Briefing for the Second Quarter of the Fiscal Year Ending December 2026
- 2026-08-19Summary Transcript of Q&A from the Financial Results Briefing for the Second Quarter of the Fiscal Year Ending December 2026
- 2026-08-14Financial Results Briefing Materials for the Second Quarter of the Fiscal Year Ending December 2026
- 2026-08-14Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending December 2026 (Japanese GAAP, Non-Consolidated)
- 2026-07-17Notice Regarding the Scheduled Time for Announcing Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending December 2026 and the Holding of Financial Results Briefings for Institutional and Individual Investors
- 2026-06-17Notice Regarding an Acquisition of Shares as Prescribed by Cabinet Order as an Act Equivalent to a Tender Offer
- 2026-06-10Notice Regarding the Launch of Information Dissemination to Shareholders and Investors via an IR Email Service
44 more
- 2026-05-25Notice of the Release of the Transcript and Video of the Briefing on Financial Results for the First Quarter of the Fiscal Year Ending December 2026
- 2026-05-25Transcript of Q&A (Summary) from the Briefing on Financial Results for the First Quarter of the Fiscal Year Ending December 2026
- 2026-05-19Notice Concerning the Status of Share Buybacks and Completion of the Buyback
- 2026-05-15Notice Regarding Completion of Payment for the Issuance of New Shares as Restricted Stock Compensation
- 2026-05-14Results Briefing Materials for the First Quarter of the Fiscal Year Ending December 2026
- 2026-05-14Financial Results for the First Quarter of the Fiscal Year Ending December 2026 (Japanese GAAP, Non-consolidated)
- 2026-05-08Notice Regarding the Status of Share Repurchases
- 2026-04-17Notice Regarding the Issuance of New Shares as Restricted Stock Compensation
- 2026-04-15Notice of the First-Quarter Financial Results Briefing for Institutional and Individual Investors for the Fiscal Year Ending December 2026
- 2026-04-02Notice Regarding the Status of Share Repurchases
- 2026-04-02Notice Regarding an Acquisition of Shares as Prescribed by Cabinet Order as an Act Equivalent to a Tender Offer
- 2026-03-31Notice Regarding the Appointment of Executive Officers and Personnel Changes
- 2026-03-30Business Plan and Growth Potential
- 2026-03-30Corporate Governance Report 2026/03/30
- 2026-03-30Articles of Incorporation 2026/03/27
- 2026-03-06Other Matters Subject to Electronic Provision for the 14th Annual General Meeting of Shareholders (Matters Omitted from the Paper Document)
- 2026-03-06Notice of Convocation and Meeting Materials for the 14th Annual General Meeting of Shareholders
- 2026-03-05Notice Regarding the Status of Share Repurchases
- 2026-02-25Notice of the Release of the Transcript and Video of the Briefing on the Fiscal Year Ended December 2025 Results and the Medium-Term Management Plan
- 2026-02-20Notice Concerning the Submission to the Annual General Meeting of Shareholders of Proposals on the Dividend from Surplus and Partial Amendments to the Articles of Incorporation
- 2026-02-18Notice of the Release of the Transcript of the Q&A Session from the Briefing on the Fiscal Year Ended December 2025 Results and the Medium-Term Management Plan (Summary)
- 2026-02-17Supplementary Information on the Decision Concerning Treasury Share Acquisitions
- 2026-02-17Notice Regarding the Decision on Matters Related to the Acquisition of Treasury Shares (Acquisition of Treasury Shares Based on Articles of Incorporation Provisions Pursuant to Article 165, Paragraph 2 of the Companies Act)
- 2026-02-16Notice Concerning Selection for Inclusion in the “JPX Startup Rapid Growth 100 Index”
- 2026-02-13Materials for the Briefing on the Fiscal Year Ended December 2025 Results and the Medium-Term Management Plan
- 2026-02-13Summary of Financial Results for the Fiscal Year Ended December 2025 (Japanese GAAP, Non-consolidated)
- 2026-01-28[For Individual Investors] Notice of Participation in the Kabu Berry Lab IR Seminar (Hybrid)
- 2026-01-27Notice of the Briefing for Institutional and Individual Investors on the Fiscal Year Ended December 2025 Results and the Medium-Term Management Plan
- 2025-12-17Notice of the Release of the Transcript and Video of “Logmi IR Meet 2025 Winter”
- 2025-12-02Notice of Participation in “Logmi IR Meet 2025 Winter”
- 2025-11-20Notice of the Release of the Transcript of the Q&A Session from the Briefing on the Fiscal Year Ended December 2025 Third-Quarter Results (Summary)
- 2025-11-20Notice of the Release of the Transcript and Video of the Briefing on the Fiscal Year Ended December 2025 Third-Quarter Results
- 2025-11-14Materials for the Briefing on Financial Results for the Fiscal Year Ended December 2025, Third Quarter
- 2025-11-14Notice Concerning the Revision of the Year-End Dividend Forecast (Increase) for the Fiscal Year Ending December 2025
- 2025-11-14Fiscal Year Ended December 2025 Third-Quarter Financial Results Summary [Japanese GAAP] (Non-Consolidated)
- 2025-10-21Notice of the Briefing for Institutional and Individual Investors on the Fiscal Year Ended December 2025 Third-Quarter Results
- 2025-08-22Notice of the Release of the Transcript and Video of the Briefing on the Fiscal Year Ended December 2025 Second-Quarter Results
- 2025-08-20Notice of the Release of the Transcript of the Q&A Session from the Briefing on the Fiscal Year Ended December 2025 Second-Quarter Results (Summary)
- 2025-08-14Materials for the Second-Quarter Financial Results Briefing for the Fiscal Year Ended December 2025
- 2025-08-14Earnings Release for the Second Quarter (Interim Period) of the Fiscal Year Ending December 2025 [Japanese GAAP] (Non-consolidated)
- 2025-07-28Notice of the Briefing for Institutional and Individual Investors on the Fiscal Year Ending December 2025 Second-Quarter (Interim-Period) Results
- 2025-05-22Notice of the Release of the Transcript and Video of the Briefing on the Fiscal Year Ended December 2025 First-Quarter Results
- 2025-05-21Notice of the Release of the Transcript of the Q&A Session from the Briefing on the Fiscal Year Ended December 2025 First-Quarter Results (Summary)
- 2025-05-16Notice Regarding Completion of Payment for the Issuance of New Shares as Restricted Stock Compensation
Threads
- 2026-08-20Preparation to Become a Platform Provider for Home Healthcare
- 2026-08-20Business Expansion and Improved Profitability
- 2026-08-20Increasing the Number of Active iBow Stations
- 2026-08-20Increasing Average Revenue per Customer
- 2026-08-20Strengthening the Development Organization to Support Market Expansion
- 2026-08-20Streamlining Billing Operations Through iBow Claims
- 2026-08-20Expansion of the Home-Visit Nursing Market
- 2026-08-20Competition and New Market Entrants
84 more
- 2026-08-20Contract Renewals by Existing Corporate Users
- 2026-08-20Market Share Exceeding 25% in the Home-Visit Nursing Market
- 2026-08-20Collecting Human Capital Metrics, Setting Targets and Considering Disclosure
- 2026-08-20Development of New Services Using AI
- 2026-08-20Tailwinds from Positive Revisions to Home-Visit Nursing Fees
- 2026-08-20Launch of the Community-Based Integrated Care Platform “けあログっと”
- 2026-08-20Managing revenue growth from existing customers using NRR
- 2026-08-19Delays in Responding to Revisions to the Health and Long-Term Care Insurance Systems
- 2026-08-19Flexible Capital Policy Through Share Repurchases
- 2026-08-19iBow Surpasses 100 Million Cumulative Visits
- 2026-08-19Numerical Targets in the 3-Year Medium-Term Management Plan
- 2026-08-19Communicating with shareholders and investors through an IR email service
- 2026-08-19Consideration of service price revisions
- 2026-08-19Consideration of Growth Investment Through M&A
- 2026-08-14The management philosophy of “making people happy”
- 2026-08-14The 2025 Problem
- 2026-08-14Acquisition of New Customers for the Core Service “iBow”
- 2026-08-14Establishment of the “iBow Administrative Support Service” Business
- 2026-08-14Price Increases, Particularly for Imported Goods
- 2026-08-14Single Segment Serving Home-Visit Nursing Stations
- 2026-08-14Performance for the Cumulative Third Quarter of 2022
- 2026-08-14Service Mix Centered on Cloud Services
- 2026-08-14Research and development activities
- 2026-08-14Expansion of the Capital Base Through a Public Offering and the Exercise of Stock Acquisition Rights
- 2026-08-14No Dividend History
- 2026-08-14Reducing and Stabilizing the Monthly Average Churn Rate at a Low Level
- 2026-08-14Dilution of share value through the exercise of stock acquisition rights
- 2026-08-14Performance-Linked Compensation and Restricted Stock Compensation
- 2026-08-14Balancing Retained Earnings with Stable Dividends
- 2026-08-14Constructive Dialogue with Shareholders and Improved Capital Efficiency
- 2026-06-17株式会社iBow's long-term holding of our shares as a stable shareholder
- 2026-05-25System Failures and Business Continuity
- 2026-05-25“iBow e-Campus: Statutory Training for Home-Visit Nursing”
- 2026-05-14Development of a Talent Referral Support Portal
- 2026-03-23Additional iBow Features
- 2026-03-23Listing on the Tokyo Stock Exchange Growth Market
- 2026-03-23Creating New Value in Home Healthcare and Realizing a Society Where Everyone Can Live with Peace of Mind
- 2026-03-23Five Values: Challenge, Innovation, Sincerity, Positivity and Professionalism
- 2026-03-23Data Business Using PHRs and Anonymously Processed Information
- 2026-03-23Support for Home-Based Clinical Trials
- 2026-03-23Promoting Digital Transformation and Electronic Records in the Home-Visit Nursing Industry
- 2026-03-23Strengthening the Business Foundation by Enhancing Internal Administration
- 2026-03-23Strengthening System Reliability, Quality and Infrastructure
- 2026-03-23Stable revenue base through cloud-based subscriptions
- 2026-03-23Attendance Management Support Through iBow KINTAI
- 2026-03-23iBow Long-Term Care Claims Transmission Service
- 2026-03-23Dependence on Specific Industries
- 2026-03-23Obstacles to Growth in the Cloud-Related Market
- 2026-03-23Dependence on the Core iBow Service for Revenue
- 2026-03-23Failure to Keep Pace with Technological Innovation
- 2026-03-23Risk of Failure to Recover Investments in New Businesses
- 2026-03-23Dependence on Outsourcing Providers
- 2026-03-23Delays in developing internal control systems as the business expands
- 2026-03-23Recruitment and Development of Human Resources and Loss of Key Personnel
- 2026-03-23Dependence on Specific Individuals
- 2026-03-23Leaks of Personal and Patient Information
- 2026-03-23Infringement of Intellectual Property Rights
- 2026-03-23Natural Disasters and Pandemics
- 2026-03-23Litigation and Damages
- 2026-03-23Impairment Losses on Fixed Assets
- 2026-03-23Information Security Management Through ISMS and Multiple Regions
- 2026-03-23Stakeholder Collaboration and Transparent, Fair Governance
- 2026-03-23Controls Through the Compliance and Risk Management Committees
- 2026-03-23Investment in iBow Feature Improvements
- 2026-03-23Stock Split to Lower the Minimum Investment Amount and Improve Market Liquidity
- 2026-03-23Recognition of Asset Retirement Obligations
- 2026-03-23Contributing to the Environment, Society and the Economy Through the Business
- 2026-03-23Considering the Development of a Sustainability Policy and Governance Structure
- 2026-03-23Deliberations and Recommendations by the Nomination and Compensation Committee
- 2026-03-23Uncertainty about the outlook due to developments surrounding the upcoming U.S. presidential election
- 2026-03-23The “e-レセ” Factoring Service for Home-Visit Nursing Providers
- 2026-03-23Risks Related to Regulation, Failures and Changes in Terms of Use by External Generative AI Providers
- 2026-03-23Foreign Exchange Risk Associated with the Use of Overseas Vendors
- 2026-03-23Advancing Development of a Care Plan Data Integration System
- 2026-03-23Risk of an economic downturn due to U.S. trade policy
- 2026-03-23Relocation of the Tokyo Office
- 2026-03-23Reducing Environmental Impact Through Reused Devices
- 2026-03-23Expansion of Outside Directors and Outside Audit & Supervisory Board Members
- 2025-03-28Residual Risk from COVID-19
- 2025-03-28Geopolitical Risk from the Russia-Ukraine Situation
- 2025-03-28Rapid Yen Depreciation Accelerates
- 2024-03-28Recoverability of Deferred Tax Assets
- 2024-03-28Relocation to the New Head Office
- 2024-03-28Administrative Action Against the Independent Auditor